Stock screener

ANIP

Conviction 4HealthcareScan · Thu, Sep 24, 2026

Ani Pharmaceuticals Inc (ANIP) closed at $74.11 (-0.43%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 49, RS Rating 18, -22.3% from its 52-week high, -5.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

ANIP$74.11-0.43%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 458.12K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
ANI PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.anipharmaceuticals.com ↗
Price74.11
Change-0.43%
Gap-0.52%
Rel volume—
Avg volume431.89K
Avg $ vol31.88M
SMA 2073.17
SMA 5076.01
SMA 20078.76
Price vs 50-2.50%
Price vs 200-5.91%
MA stackbearish
50/200 cross—
Supertrendup · 70.86
RSI (14)49
MACD hist0.61
MACD crossbull · 7d
Stoch %K / %D46 / 60
ADX (14)18
+DI / −DI23 / 17
RSI divergence—
MACD divergenceBullish
ATR %3.28%
ADR %2.91%
52w high95.38
52w low70.19
From 52w high-22.30%
Above 52w low+5.58%
New 52w highNo
SqueezeOff
Bollinger width13.02%
%B0.60
Donchian pos45.99%
Donchian high79.43
Donchian low69.58
AVWAP (52w high)80.10
vs AVWAP high-7.48%
AVWAP (52w low)74.71
vs AVWAP low-0.80%
OBV trendFlat
Chaikin MF (20)-0.03
Today vs 20d—
Avg vol (14d)458.12K
Avg vol (20d)431.89K
Avg $ vol (20d)31.88M
Market cap1.81B
RS Rating18 / 99
RS 3m (vs SPY)-15.50%
RS 6m (vs SPY)-16.76%
RS line new highNo
Trend template1/8
Technical rank42.5
1 week-1.70%
1 month-2.04%
3 months-11.01%
6 months+0.05%
1 year-22.26%
YTD-5.51%
P/E23.10
P/B3.03
P/S2.05
P/FCF10.56
EPS3.32
Div yield0.06%
ROE13.12%
ROA5.24%
Debt/Eq0.50
Current2.91
EV/EBITDA11.06
Gross margin—
Net margin8.87%
Rev growth43.78%
EPS growth522.94%
Price target106.75
Target upside44.04%
Analyst ratingBuy
Institutional106.63%
Ent. value1.75B
Revenue266.04M
Net income24.71M
Gross profit—
Free cash flow171.39M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out22.73M
Employees970
ListedMon, Sep 13, 1999
Free float19.39M
Float %85.2%
Short interest3.36M
Days to cover9.2d
Short volume63.9%
Squeeze score76 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.82 vs $1.67
Last surprise+9.0% beat
Setup gradeD
Conviction4 / 100
Pattern quality—
Tech rank42.5 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance81.32
Support70.57
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ANIP

All disclosures →
No recent disclosed trades by Congress in ANIP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ANIP · open-market 7 sells

InsiderSideShares
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. · Common Stock · 2026-09-14
Sell500
Thoma Jeanne
Director · Common Stock · 2026-09-11
Sell1K
CAREY STEPHEN P.
SVP & CFO · Common Stock · 2026-08-31
Sell2.85K
Gosebruch Henry O
Director · Common Stock · 2026-08-19
Grant6.66K
Lalwani Nikhil
PRESIDENT & CEO · Common Stock · 2026-08-25
Sell5.4K
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. · Common Stock · 2026-08-13
Sell500
Gutwerg Ori
SVP, GENERICS · Common Stock · 2026-08-10
Sell3.16K
CAREY STEPHEN P.
SVP & CFO · Common Stock · 2026-07-02
Exercise3.31K
CAREY STEPHEN P.
SVP & CFO · Common Stock · 2026-07-02
Sell3.31K
CAREY STEPHEN P.
SVP & CFO · Stock Option (right to buy) · 2026-07-02
Exercise3.31K

SEC filings

EDGAR filings in ANIP · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.